Melbourne will soon open Clarion Clinics’ first exclusively dedicated facility to provide psychedelic-assisted therapies legalized in Australia.
The subsidiary to biotech Incannex Healthcare (NASDAQ: IXHL) received the required Human Research Ethics Committee (HREC) endorsement for the administration of MDMA and psilocybin therapies for PTSD and Treatment-Resistant Depression (TRD) respectively.
Reportedly “the only dedicated psychedelic-assisted therapy clinic in Australia” with a team comprised of renowned researchers, psychologists and psychiatrists, Clarion Clinics announced its intentions to open more clinics across the country and internationally.
For those among the city’s 5.2 million in need of treatment, regulations indicate that their psychiatrists must also receive HREC endorsement for their qualifications and experience and for the treatment’s protocols.
The Australian Therapeutic Goods Administration ...